Literature DB >> 15845029

Analysis of dystrophin gene deletions indicates that the hinge III region of the protein correlates with disease severity.

A Carsana1, G Frisso, M R Tremolaterra, R Lanzillo, D F Vitale, L Santoro, F Salvatore.   

Abstract

We have investigated the frequency of deletions in the dystrophin gene in 108 unrelated Duchenne and Becker muscular dystrophy (DMD/BMD) patients from southern Italy (DMD, n. 47; BMD, n. 61) and identified 89 deletions. The de novo mutation rate (about 30%), and the preferentially maternal origin of deletional mutations, analysed in families in which the maternal grandparents were available or their haplotypes could be unequivocally reconstructed, are in agreement with data reported for other populations. The correlation between BMD phenotype and type of deletion suggests that, in the distal rod domain region, the deletion size may not be as crucial as the particular combination of missing exons. In fact, we provide immunohistochemical and clinical evidence that in-frame deletion of the hinge III region in the distal rod domain results in a milder phenotype as compared with shorter deletions that do not include the hinge III region. Our data obtained in BMD patients, by confirming inferences arising from minigene transfection experiments in mdx mice, represent an important contribution to gene therapy approaches.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15845029     DOI: 10.1046/j.1529-8817.2005.00160.x

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN: 0003-4800            Impact factor:   1.670


  29 in total

Review 1.  Syntrophins entangled in cytoskeletal meshwork: Helping to hold it all together.

Authors:  Sahar S Bhat; Roshia Ali; Firdous A Khanday
Journal:  Cell Prolif       Date:  2018-12-04       Impact factor: 6.831

2.  A larger spectrum of intragenic short tandem repeats improves linkage analysis and localization of intragenic recombination detection in the dystrophin gene: an analysis of 93 families from southern Italy.

Authors:  Antonella Carsana; Giulia Frisso; Maria Roberta Tremolaterra; Elisabetta Ricci; Domenico De Rasmo; Francesco Salvatore
Journal:  J Mol Diagn       Date:  2007-02       Impact factor: 5.568

3.  Deletional mutations of dystrophin gene and carrier detection in eastern India.

Authors:  Jayasri Basak; Uma B Dasgupta; Subhash Chandra Mukherjee; Shyamal Kumar Das; Asit Kumar Senapati; Tapas Kumar Banerjee
Journal:  Indian J Pediatr       Date:  2009-11-12       Impact factor: 1.967

4.  Dystrophin hydrophobic regions in the pathogenesis of Duchenne and Becker muscular dystrophies.

Authors:  Yingyin Liang; Songlin Chen; Jianzong Zhu; Xiangxue Zhou; Chen Yang; Lu Yao; Cheng Zhang
Journal:  Bosn J Basic Med Sci       Date:  2015-05-20       Impact factor: 3.363

5.  Precise mapping of 17 deletion breakpoints within the central hotspot deletion region (introns 50 and 51) of the DMD gene.

Authors:  Gabriella Esposito; Maria Roberta Tremolaterra; Evelina Marsocci; Igor Cm Tandurella; Tiziana Fioretti; Maria Savarese; Antonella Carsana
Journal:  J Hum Genet       Date:  2017-09-07       Impact factor: 3.172

6.  A Single CRISPR-Cas9 Deletion Strategy that Targets the Majority of DMD Patients Restores Dystrophin Function in hiPSC-Derived Muscle Cells.

Authors:  Courtney S Young; Michael R Hicks; Natalia V Ermolova; Haruko Nakano; Majib Jan; Shahab Younesi; Saravanan Karumbayaram; Chino Kumagai-Cresse; Derek Wang; Jerome A Zack; Donald B Kohn; Atsushi Nakano; Stanley F Nelson; M Carrie Miceli; Melissa J Spencer; April D Pyle
Journal:  Cell Stem Cell       Date:  2016-02-11       Impact factor: 24.633

7.  Diagnostic Accuracy of Phenotype Classification in Duchenne and Becker Muscular Dystrophy Using Medical Record Data1.

Authors:  Jennifer G Andrews; Molly M Lamb; Kristin Conway; Natalie Street; Christina Westfield; Emma Ciafaloni; Dennis Matthews; Christopher Cunniff; Shree Pandya; Deborah J Fox
Journal:  J Neuromuscul Dis       Date:  2018

8.  Dystrophin genotype-cardiac phenotype correlations in Duchenne and Becker muscular dystrophies using cardiac magnetic resonance imaging.

Authors:  Animesh Tandon; John L Jefferies; Chet R Villa; Kan N Hor; Brenda L Wong; Stephanie M Ware; Zhiqian Gao; Jeffrey A Towbin; Wojciech Mazur; Robert J Fleck; Joshua J Sticka; D Woodrow Benson; Michael D Taylor
Journal:  Am J Cardiol       Date:  2015-01-15       Impact factor: 2.778

9.  Duchenne muscular dystrophy gene therapy: Lost in translation?

Authors:  Dongsheng Duan
Journal:  Res Rep Biol       Date:  2011-03

10.  The polyproline site in hinge 2 influences the functional capacity of truncated dystrophins.

Authors:  Glen B Banks; Luke M Judge; James M Allen; Jeffrey S Chamberlain
Journal:  PLoS Genet       Date:  2010-05-20       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.